On Tuesday, Tandem Diabetes Care Inc (NASDAQ: TNDM) was -4.85% drop from the session before settling in for the closing price of $35.23. A 52-week range for TNDM has been $22.03 – $53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 21.47% over the last five years. When this article was written, the company’s average yearly earnings per share was at 50.60%. With a float of $65.02 million, this company’s outstanding shares have now reached $65.65 million.
The firm has a total of 2400 workers. Let’s measure their productivity. In terms of profitability, gross margin is 43.69%, operating margin of -13.72%, and the pretax margin is -12.65%.
Tandem Diabetes Care Inc (TNDM) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tandem Diabetes Care Inc stocks. The insider ownership of Tandem Diabetes Care Inc is 1.00%, while institutional ownership is 117.58%. The most recent insider transaction that took place on Nov 21 ’24, was worth 941,400. In this transaction Director of this company sold 30,000 shares at a rate of $31.38, taking the stock ownership to the 165,190 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Director sold 10,000 for $30.00, making the entire transaction worth $300,000. This insider now owns 195,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.39% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
You can see what Tandem Diabetes Care Inc (TNDM) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Analysing the last 5-days average volume posted by the [Tandem Diabetes Care Inc, TNDM], we can find that recorded value of 0.89 million was lower than the volume posted last year of 0.92 million. As of the previous 9 days, the stock’s Stochastic %D was 19.38%. Additionally, its Average True Range was 1.57.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 31.15%, which indicates a significant increase from 11.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.10% in the past 14 days, which was lower than the 50.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.12, while its 200-day Moving Average is $39.43. Now, the first resistance to watch is $34.58. This is followed by the second major resistance level at $35.63. The third major resistance level sits at $36.45. If the price goes on to break the first support level at $32.71, it is likely to go to the next support level at $31.89. Should the price break the second support level, the third support level stands at $30.84.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
There are 65,677K outstanding shares of the company, which has a market capitalization of 2.20 billion. As of now, sales total 747,720 K while income totals -222,610 K. Its latest quarter income was 243,970 K while its last quarter net income were -23,250 K.
